Special Issue "Imaging of Bone Metastases in Oncology"
Deadline for manuscript submissions: closed (31 January 2018)
Prof. Lars J. Petersen
Department of Nuclear Medicine, Aalborg University Hospital, and Department of Clinical Medicine, The Faculty of Medicine, Aalborg University, Aalborg, Denmark
Website | E-Mail
Interests: prostate cancer imaging; bone imaging; oncology; evidence based medicine; research methodology; systematic reviews and meta-analysis
Bone metastases are well known complications to advanced cancer, e.g., in common cancers like prostate, breast, and lung cancer. Imaging of bone metastases are key in staging, suspected recurrent disease, and for treatment monitoring of palliative care in metastatic disease. Imaging modalities like bone scintigraphy, X-ray, and CT have standard of care in the last decades. Newer modalities like PET/CT with various tracers and diffusion-weighed MRI have been introduced with apparent premium diagnostic performance. Modern imaging modalities also offer opportunities for quantitative analysis of bone lesions with improved prognostic values. Improved detection rates raise the question of stage migration, e.g., how to define and treat oligometastatic disease. From a diagnostic test accuracy perspective, bone metastases may be difficult to handle for several reasons, including failure to obtain a valid reference for the presence or absence of maliognancy, in particular at the lesional level. This Special Issue provides an up to date view of the advances made towards imaging of bone metastases in oncology. It canvasses all fields and modalities of imaging of bone metastases, from diagnosis, prognosis, comparative studies with other biomarkers, research methodology, health care analyses, and guidelines.
Prof. Lars J. Petersen
Assoc. Prof. Helle D. Zacho
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Bone metastases
- Diagnostic test accuracy studies
- Diffusion-weighted MRI
- Image quantification
- Research methodology
- Health care outcome